Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00DBH
|
||||
Former ID |
DIB000447
|
||||
Drug Name |
NPS 1776
|
||||
Synonyms |
Isovaleramide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Epilepsy [ICD10:G40] | Discontinued in Phase 2 | [1] | ||
Company |
NPS Pharmaceuticals
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C5H11NO
|
||||
Canonical SMILES |
CC(C)CC(=O)N
|
||||
InChI |
1S/C5H11NO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H2,6,7)
|
||||
InChIKey |
SANOUVWGPVYVAV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldehyde dehydrogenase | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010984) | ||||
REF 2 | Diverse Mechanisms of Antiepileptic Drugs in the Development Pipeline. Epilepsy Res. 2006 June; 69(3): 273-294. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.